Cellvizio, advanced endomicroscopy technology from Mauna Kea Technologies, allows surgeons to rule out precancerous or cancerous cells prior to performing anti-reflux surgery. “Instead of taking biopsy tissue to a microscope to identify cancer in patients with GERD, with Cellvizio we are taking the microscopy to the tissue,” said V. John Bagnato, MD, a surgeon at Coliseum Northside Hospital.
More articles on gastroenterology:
3 devices designed to improve CRC detection rates & care
How has healthcare reform affected gastroenterology?
3 GI/endoscopy coding & billing tips
